CLEVER CULTURE SYSTEMS LIMITED - Announcements

2.86%

3.6¢

Market Cap $65.33M

Healthcare Biotechnology

Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based... Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based company that provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence (AI) and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates. The technology is a United States FDA-cleared AI technology for automated culture plate reading. The product is being sold to microbiology laboratories in the pharmaceutical manufacturing sector for the reading of environmental monitoring culture plates and to clinical laboratories as an in vitro diagnostic for infectious diseases. Thermo Fisher Scientific, Inc is the exclusive distributor of the APAS Independence to clinical customers in the United States and selected countries in Europe.More

Announcements

Filter Results

All Price Sensitive Only

CC5	Notification regarding unquoted securities - LBT		23/03/23	27.84KB	Share
CC5	Application for quotation of securities - LBT		23/03/23	25.37KB	Share
CC5	Proposed issue of securities - LBT		20/03/23	29.73KB	Share
CC5	Placement Supports APAS Pharma & EU Expansion	PRICE SENSITIVE	20/03/23	174.43KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	1.17MB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/01/23	463.53KB	Share
CC5	LBT Company Presentation		20/01/23	1.03MB	Share
CC5	Quarterly Investor Call		19/01/23	106.85KB	Share
CC5	Notification of cessation of securities - LBT		11/01/23	21.71KB	Share
CC5	AstraZeneca Partners LBT for APAS Pharma Development	PRICE SENSITIVE	09/01/23	117.2KB	Share
CC5	Release from Escrow		03/01/23	86.54KB	Share
CC5	LBT Strengthens APAS Pharma Development	PRICE SENSITIVE	20/12/22	110.44KB	Share
CC5	CCS Appoint Thermo Fisher as Exclusive European Distributor	PRICE SENSITIVE	19/12/22	115.88KB	Share
CC5	Appendix 3Y - all Directors		02/12/22	268.2KB	Share
CC5	Notice under s708A - Cleansing Notice		28/11/22	86.3KB	Share
CC5	Notification regarding unquoted securities - LBT		28/11/22	23.99KB	Share
CC5	Application for quotation of securities - LBT		28/11/22	24.92KB	Share
CC5	Non-renounceable Rights Issue Results	PRICE SENSITIVE	28/11/22	114.71KB	Share
CC5	Application for quotation of securities - LBT		25/11/22	24.83KB	Share
CC5	Entitlement Offer Letters Mailed to Shareholders		01/11/22	346.05KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	456.94KB	Share
CC5	Application for quotation of securities - LBT		31/10/22	25.02KB	Share
CC5	Application for quotation of securities - LBT		26/10/22	24.88KB	Share
CC5	Proposed issue of securities - LBT		26/10/22	24.76KB	Share
CC5	Results of Meeting		26/10/22	154.28KB	Share
CC5	Chair's Address to Shareholders		26/10/22	155.46KB	Share
CC5	CEO Presentation		26/10/22	994.52KB	Share
CC5	LBT Receives $1,206,058 R&D Tax Incentive		25/10/22	134.71KB	Share
CC5	Proposed issue of securities - LBT		25/10/22	33.28KB	Share
CC5	Rights Issue Prospectus	PRICE SENSITIVE	25/10/22	630.34KB	Share
CC5	Non-Renounceable Rights Issue	PRICE SENSITIVE	25/10/22	198.85KB	Share
CC5	$1.5M Funding Awarded for New APAS Instrument	PRICE SENSITIVE	24/10/22	207.89KB	Share
CC5	Notification of cessation of securities - LBT		17/10/22	22.22KB	Share
CC5	Notice of Annual General Meeting/Proxy Form		21/09/22	619.17KB	Share
CC5	BioPhorum Presentation		14/09/22	2.32MB	Share
CC5	APAS Independence Market Update		13/09/22	132.28KB	Share
CC5	Company Presentation ASX Small and Mid-Cap Conference		13/09/22	1020.52KB	Share
CC5	New Data Published on APAS Technology		31/08/22	128.29KB	Share
CC5	Appendix 4G		29/08/22	272.99KB	Share
CC5	Corporate Governance Statement		29/08/22	274.9KB	Share
CC5	Annual Report to shareholders		29/08/22	2.88MB	Share
CC5	Appendix 4E	PRICE SENSITIVE	29/08/22	126.33KB	Share
CC5	Application for quotation of securities - LBT		24/08/22	27.24KB	Share
CC5	Proposed issue of securities - LBT		16/08/22	25.34KB	Share
CC5	Updated Product Pipeline Strategy Announced		10/08/22	440.9KB	Share
CC5	Notification of cessation of securities - LBT		03/08/22	21.64KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	284.83KB	Share
CC5	APAS Independence Showcased at Major US Microbiology Conf		14/06/22	512.95KB	Share
CC5	Direct Sale of APAS Independence in United States	PRICE SENSITIVE	03/05/22	174.44KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	451.86KB	Share
CC5	Clinical Data Featuring APAS Technology Presented at ECCMID		27/04/22	187.44KB	Share
CC5	Purchase Order for Multiple APAS Instruments	PRICE SENSITIVE	16/03/22	154.35KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/22	948.1KB	Share
CC5	LBT Receives $824,500 R&D Tax Incentive		15/02/22	134.36KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/22	357.01KB	Share
CC5	Notification regarding unquoted securities - LBT		13/01/22	27.52KB	Share
CC5	Notification of cessation of securities - LBT		12/01/22	21.58KB	Share
CC5	LBT Investor Call to discuss CCS Acquisition	PRICE SENSITIVE	11/01/22	995.92KB	Share
CC5	LBT Completes CCS Acquisition		04/01/22	208.66KB	Share
CC5	Notice of Initial Substantial Holder		04/01/22	43.88KB	Share
CC5	LBT Completes CCS Acquisition	PRICE SENSITIVE	04/01/22	131.87KB	Share
CC5	Appendix 3Y - Simon Arkell		30/12/21	170.7KB	Share
CC5	Appendix 3Y - Damian Lismore		30/12/21	170.79KB	Share
CC5	Appendix 3Y - Brian O'Dwyer		30/12/21	171.2KB	Share
CC5	Appendix 3Y - Joanne Moss		30/12/21	171.58KB	Share
CC5	Notice under Section 708A - Cleansing Notice		30/12/21	88.08KB	Share
CC5	Notification regarding unquoted securities - LBT		30/12/21	27.68KB	Share
CC5	Application for quotation of securities - LBT		30/12/21	25.05KB	Share
CC5	Update - Proposed issue of securities - LBT		29/12/21	27.98KB	Share
CC5	Notification regarding unquoted securities - LBT		29/12/21	26.11KB	Share
CC5	Notification regarding unquoted securities - LBT		29/12/21	23.72KB	Share
CC5	Application for quotation of securities - LBT		29/12/21	24.76KB	Share
CC5	Proposed issue of securities - LBT		29/12/21	28.15KB	Share
CC5	LBT to Obtain Full Ownership of CCS Joint Venture	PRICE SENSITIVE	29/12/21	146.74KB	Share
CC5	Market Update - Sales Pipeline and Evaluations	PRICE SENSITIVE	08/12/21	163.72KB	Share
CC5	Results of Meeting		30/11/21	163.07KB	Share
CC5	CEO Presentation - AGM 2021		29/11/21	1.18MB	Share
CC5	Chair's Address to Shareholders - AGM 2021		29/11/21	142.79KB	Share
CC5	Jobkeeper Payments Notification		24/11/21	31.45KB	Share
CC5	US FDA 510(k) Clearance for MRSA Analysis Module	PRICE SENSITIVE	29/10/21	335.82KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/21	444.4KB	Share
CC5	Notice of Annual General Meeting/Proxy Form		27/10/21	765.55KB	Share
CC5	Presentation at Australia Biotech Invest & Partnering 2021		26/10/21	1.36MB	Share
CC5	SA Government Extends Loan Repayment Schedule		08/10/21	159.54KB	Share
CC5	Final Director's Interest Notice		01/10/21	264.87KB	Share
CC5	Kate Costello Retires as Director and Chair of the Board		30/09/21	141.83KB	Share
CC5	Appendix 4G		30/09/21	302.12KB	Share
CC5	Corporate Governance Statement		30/09/21	281.89KB	Share
CC5	Annual Report to shareholders		29/09/21	3.35MB	Share
CC5	Initial Director's Interest Notice		28/09/21	215.9KB	Share
CC5	Company Presentation Thermo Fisher Appointed US Distributor		28/09/21	1.37MB	Share
CC5	Appointment of Laboratory Leader to the Board		28/09/21	173.07KB	Share
CC5	CCS Appoints Thermo Fisher as Exclusive US APAS Distributor	PRICE SENSITIVE	27/09/21	185.99KB	Share
CC5	Investor Webinar Presentation		09/09/21	160.7KB	Share
CC5	Appendix 4E and Annual Financial Statements	PRICE SENSITIVE	26/08/21	1.49MB	Share
CC5	Leading Microbiology Journal Publishes APAS Clinical Data		18/08/21	124.73KB	Share
CC5	Notification of cessation of securities - LBT		03/08/21	22.15KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/21	335.85KB	Share
CC5	APAS Independence Scientific Data Presented at ECCMID		09/07/21	133.67KB	Share
CC5	Proposed issue of securities - LBT		01/07/21	26.8KB	Share

CC5 Notification regarding unquoted securities - LBT
23/03/23		27.84KB	Share
CC5 Application for quotation of securities - LBT
23/03/23		25.37KB	Share
CC5 Proposed issue of securities - LBT
20/03/23		29.73KB	Share
CC5 Placement Supports APAS Pharma & EU Expansion
20/03/23	PRICE SENSITIVE	174.43KB	Share
CC5 Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	1.17MB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
23/01/23	PRICE SENSITIVE	463.53KB	Share
CC5 LBT Company Presentation
20/01/23		1.03MB	Share
CC5 Quarterly Investor Call
19/01/23		106.85KB	Share
CC5 Notification of cessation of securities - LBT
11/01/23		21.71KB	Share
CC5 AstraZeneca Partners LBT for APAS Pharma Development
09/01/23	PRICE SENSITIVE	117.2KB	Share
CC5 Release from Escrow
03/01/23		86.54KB	Share
CC5 LBT Strengthens APAS Pharma Development
20/12/22	PRICE SENSITIVE	110.44KB	Share
CC5 CCS Appoint Thermo Fisher as Exclusive European Distributor
19/12/22	PRICE SENSITIVE	115.88KB	Share
CC5 Appendix 3Y - all Directors
02/12/22		268.2KB	Share
CC5 Notice under s708A - Cleansing Notice
28/11/22		86.3KB	Share
CC5 Notification regarding unquoted securities - LBT
28/11/22		23.99KB	Share
CC5 Application for quotation of securities - LBT
28/11/22		24.92KB	Share
CC5 Non-renounceable Rights Issue Results
28/11/22	PRICE SENSITIVE	114.71KB	Share
CC5 Application for quotation of securities - LBT
25/11/22		24.83KB	Share
CC5 Entitlement Offer Letters Mailed to Shareholders
01/11/22		346.05KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	456.94KB	Share
CC5 Application for quotation of securities - LBT
31/10/22		25.02KB	Share
CC5 Application for quotation of securities - LBT
26/10/22		24.88KB	Share
CC5 Proposed issue of securities - LBT
26/10/22		24.76KB	Share
CC5 Results of Meeting
26/10/22		154.28KB	Share
CC5 Chair's Address to Shareholders
26/10/22		155.46KB	Share
CC5 CEO Presentation
26/10/22		994.52KB	Share
CC5 LBT Receives $1,206,058 R&D Tax Incentive
25/10/22		134.71KB	Share
CC5 Proposed issue of securities - LBT
25/10/22		33.28KB	Share
CC5 Rights Issue Prospectus
25/10/22	PRICE SENSITIVE	630.34KB	Share
CC5 Non-Renounceable Rights Issue
25/10/22	PRICE SENSITIVE	198.85KB	Share
CC5 $1.5M Funding Awarded for New APAS Instrument
24/10/22	PRICE SENSITIVE	207.89KB	Share
CC5 Notification of cessation of securities - LBT
17/10/22		22.22KB	Share
CC5 Notice of Annual General Meeting/Proxy Form
21/09/22		619.17KB	Share
CC5 BioPhorum Presentation
14/09/22		2.32MB	Share
CC5 APAS Independence Market Update
13/09/22		132.28KB	Share
CC5 Company Presentation ASX Small and Mid-Cap Conference
13/09/22		1020.52KB	Share
CC5 New Data Published on APAS Technology
31/08/22		128.29KB	Share
CC5 Appendix 4G
29/08/22		272.99KB	Share
CC5 Corporate Governance Statement
29/08/22		274.9KB	Share
CC5 Annual Report to shareholders
29/08/22		2.88MB	Share
CC5 Appendix 4E
29/08/22	PRICE SENSITIVE	126.33KB	Share
CC5 Application for quotation of securities - LBT
24/08/22		27.24KB	Share
CC5 Proposed issue of securities - LBT
16/08/22		25.34KB	Share
CC5 Updated Product Pipeline Strategy Announced
10/08/22		440.9KB	Share
CC5 Notification of cessation of securities - LBT
03/08/22		21.64KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	284.83KB	Share
CC5 APAS Independence Showcased at Major US Microbiology Conf
14/06/22		512.95KB	Share
CC5 Direct Sale of APAS Independence in United States
03/05/22	PRICE SENSITIVE	174.44KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	451.86KB	Share
CC5 Clinical Data Featuring APAS Technology Presented at ECCMID
27/04/22		187.44KB	Share
CC5 Purchase Order for Multiple APAS Instruments
16/03/22	PRICE SENSITIVE	154.35KB	Share
CC5 Half Yearly Report and Accounts
25/02/22	PRICE SENSITIVE	948.1KB	Share
CC5 LBT Receives $824,500 R&D Tax Incentive
15/02/22		134.36KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22	PRICE SENSITIVE	357.01KB	Share
CC5 Notification regarding unquoted securities - LBT
13/01/22		27.52KB	Share
CC5 Notification of cessation of securities - LBT
12/01/22		21.58KB	Share
CC5 LBT Investor Call to discuss CCS Acquisition
11/01/22	PRICE SENSITIVE	995.92KB	Share
CC5 LBT Completes CCS Acquisition
04/01/22		208.66KB	Share
CC5 Notice of Initial Substantial Holder
04/01/22		43.88KB	Share
CC5 LBT Completes CCS Acquisition
04/01/22	PRICE SENSITIVE	131.87KB	Share
CC5 Appendix 3Y - Simon Arkell
30/12/21		170.7KB	Share
CC5 Appendix 3Y - Damian Lismore
30/12/21		170.79KB	Share
CC5 Appendix 3Y - Brian O'Dwyer
30/12/21		171.2KB	Share
CC5 Appendix 3Y - Joanne Moss
30/12/21		171.58KB	Share
CC5 Notice under Section 708A - Cleansing Notice
30/12/21		88.08KB	Share
CC5 Notification regarding unquoted securities - LBT
30/12/21		27.68KB	Share
CC5 Application for quotation of securities - LBT
30/12/21		25.05KB	Share
CC5 Update - Proposed issue of securities - LBT
29/12/21		27.98KB	Share
CC5 Notification regarding unquoted securities - LBT
29/12/21		26.11KB	Share
CC5 Notification regarding unquoted securities - LBT
29/12/21		23.72KB	Share
CC5 Application for quotation of securities - LBT
29/12/21		24.76KB	Share
CC5 Proposed issue of securities - LBT
29/12/21		28.15KB	Share
CC5 LBT to Obtain Full Ownership of CCS Joint Venture
29/12/21	PRICE SENSITIVE	146.74KB	Share
CC5 Market Update - Sales Pipeline and Evaluations
08/12/21	PRICE SENSITIVE	163.72KB	Share
CC5 Results of Meeting
30/11/21		163.07KB	Share
CC5 CEO Presentation - AGM 2021
29/11/21		1.18MB	Share
CC5 Chair's Address to Shareholders - AGM 2021
29/11/21		142.79KB	Share
CC5 Jobkeeper Payments Notification
24/11/21		31.45KB	Share
CC5 US FDA 510(k) Clearance for MRSA Analysis Module
29/10/21	PRICE SENSITIVE	335.82KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21	PRICE SENSITIVE	444.4KB	Share
CC5 Notice of Annual General Meeting/Proxy Form
27/10/21		765.55KB	Share
CC5 Presentation at Australia Biotech Invest & Partnering 2021
26/10/21		1.36MB	Share
CC5 SA Government Extends Loan Repayment Schedule
08/10/21		159.54KB	Share
CC5 Final Director's Interest Notice
01/10/21		264.87KB	Share
CC5 Kate Costello Retires as Director and Chair of the Board
30/09/21		141.83KB	Share
CC5 Appendix 4G
30/09/21		302.12KB	Share
CC5 Corporate Governance Statement
30/09/21		281.89KB	Share
CC5 Annual Report to shareholders
29/09/21		3.35MB	Share
CC5 Initial Director's Interest Notice
28/09/21		215.9KB	Share
CC5 Company Presentation Thermo Fisher Appointed US Distributor
28/09/21		1.37MB	Share
CC5 Appointment of Laboratory Leader to the Board
28/09/21		173.07KB	Share
CC5 CCS Appoints Thermo Fisher as Exclusive US APAS Distributor
27/09/21	PRICE SENSITIVE	185.99KB	Share
CC5 Investor Webinar Presentation
09/09/21		160.7KB	Share
CC5 Appendix 4E and Annual Financial Statements
26/08/21	PRICE SENSITIVE	1.49MB	Share
CC5 Leading Microbiology Journal Publishes APAS Clinical Data
18/08/21		124.73KB	Share
CC5 Notification of cessation of securities - LBT
03/08/21		22.15KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
28/07/21	PRICE SENSITIVE	335.85KB	Share
CC5 APAS Independence Scientific Data Presented at ECCMID
09/07/21		133.67KB	Share
CC5 Proposed issue of securities - LBT
01/07/21		26.8KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.6¢		Change 0.001(2.86%)		Mkt cap ! $65.33M

Open	High	Low	Value	Volume
3.5¢	3.6¢	3.5¢	$18.02K	513.3K

Buyers (Bids)

No.	Vol.	Price($)
7	991682	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	1072927	5

View Market Depth

No.	Vol.	Price($)
7	991682	0.034
6	971865	0.033
4	504275	0.032
1	32258	0.031
4	618150	0.030

Price($)	Vol.	No.
0.036	1072927	5
0.037	1353817	1
0.039	1128436	4
0.040	3000000	2
0.041	300000	1

Last trade - 15.55pm 21/08/2025 (20 minute delay)


Last 3.6¢		Change 0.001 ( 2.86 %)
Open	High	Low	Volume
3.5¢	3.6¢	3.5¢	84104
Last updated 15.55pm 21/08/2025 ?

CC5 (ASX) Chart

CLEVER CULTURE SYSTEMS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories